From July 2002 to December 2009, women who had a gene mutation for Lynch syndrome, met the Amsterdam II criteria, or had a high-risk situation that required screening were prospectively enrolled.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback